This paper is in the following e-collection/theme issue:

NIH funded proposals with peer-review reports (USA) (112) Pharmacology and Pharmaceutics (110) Gastroenterology and Hepatology (126)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50513, first published .
Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Authors of this article:

Evan L Fogel1 Author Orcid Image ;   Jeffrey J Easler1 Author Orcid Image ;   Ying Yuan2 Author Orcid Image ;   Dhiraj Yadav3 Author Orcid Image ;   Darwin L Conwell3 Author Orcid Image ;   Santhi Swaroop Vege4 Author Orcid Image ;   Samuel Y Han5 Author Orcid Image ;   Walter Park6 Author Orcid Image ;   Vanessa Patrick1 Author Orcid Image ;   Fletcher A White7 Author Orcid Image
Article Authors Cited by (2) Tweetations (4) Metrics

Journals

  1. Kuhlmann L, Olesen S, Drewes A. Pathophysiology, Assessment, and Management of Pain Associated with Chronic Pancreatitis. Gastroenterology Clinics of North America 2025;54(1):129 View
  2. Lin Z, Pandol S, Apte M, Jiang Y. Navigating chronic pancreatitis pain: a pathophysiological and therapeutic overview. Frontiers in Physiology 2025;16 View